EUVIMEDEUVIMED entdecken
Crossref

Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury

Yihan Xing, Vy Do, Zunkai Xu, Clara Do, Canyuan Yang, Ziyue Zhu, Jingjing Gao

ACS Nano Medicine · 02.11.2026

DOI: 10.1021/acsnanomed.6c00153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 02.11.2026. Verfasst von Yihan Xing und 6 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Alzheimer's Association.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI)-induced neuroinflammation can evolve over weeks or months, contributing to ongoing secondary damage and worsening neurological recovery. RNA-based therapeutics hold great potential to regulate inflammatory signaling, but delivery to the brain remains challenging because of the blood–brain barrier. Intranasal administration offers a direct, noninvasive route for brain access but is often limited by low delivery efficiency. Here, we constructed a combinatorial library of 103 DNA-barcoded lipid nanoparticles by varying lipid components with diverse headgroup chemistries and bioreactive moieties. A high-throughput screening of these nanoparticles in vivo following intranasal administration led to the identification of top candidates with the highest normalized DNA barcode brain delivery. Intranasal delivery of an antagomir targeting microRNA-9-5p loaded in a nanoparticle effectively reduced cerebral microRNA-9-5p levels, suppressed inflammatory markers, and improved neurological outcomes in TBI. These results demonstrate a systematic approach for optimizing intranasal lipid nanoparticle design and support the feasibility of RNA delivery to modulate neuroinflammation after brain injury.

Förderung

  • Alzheimer's Association

Zitieren

APA

Xing, Y., Do, V., Xu, Z., Do, C., Yang, C., Zhu, Z., & Gao, J. (2026). Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury. ACS Nano Medicine. https://doi.org/10.1021/acsnanomed.6c00153

Vancouver

Xing Y, Do V, Xu Z, Do C, Yang C, Zhu Z, et al. Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury. ACS Nano Medicine. 2026. doi:10.1021/acsnanomed.6c00153

BibTeX
@article{Xing2026,
  author = {Xing, Yihan and Do, Vy and Xu, Zunkai and Do, Clara and Yang, Canyuan and Zhu, Ziyue and Gao, Jingjing},
  title = {Combinatorial Screening of Nanoparticles for Nose-to-Brain RNA Delivery to Modulate Neuroinflammation after Traumatic Brain Injury},
  journal = {ACS Nano Medicine},
  year = {2026},
  doi = {10.1021/acsnanomed.6c00153}
}
Kostenlos starten →